Drug intelligence / Profile preview

diosmin + troxerutin + hesperidin

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

A combination product containing **diosmin**, **troxerutin**, and **hesperidin** is a mixture of three flavonoids used primarily for the management of acute hemorrhoidal disease and symptoms of venous insufficiency. All three components are vasoprotective flavonoids: - **Diosmin** is a semisynthetic flavonoid that primarily prolongs the vasoconstrictor effect of norepinephrine on the venous wall, leading to decreased capillary permeability and increased venous tone. - **Troxerutin** is a hydroxyethyl derivative of rutin (classified as a flavonol), exerting antioxidant, anti-inflammatory, and venotonic effects—stabilizing capillary permeability and improving microcirculation. - **Hesperidin** is a citrus flavonoid glycoside with vasoprotective and anti-inflammatory activities, often acting synergistically with diosmin. The combination acts by reducing venous stasis, edema, pain, and bleeding associated with hemorrhoids and other chronic venous disorders. Its mechanism involves enhancement of vein tone, reduction of vascular permeability, improvement of lymphatic drainage, and anti-inflammatory properties. It has demonstrated safety and efficacy in randomized controlled trials in acute hemorrhoidal disease and has also been studied for symptoms associated with pelvic congestion syndrome[1][2].

02

Targets

AR (Adrenergic receptors)PPARA (Peroxisome proliferator-activated receptor alpha)PPARG (Peroxisome proliferator-activated receptor gamma)Acetylcholinesterase

Beyond the preview

Go deeper on diosmin + troxerutin + hesperidin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diosmin + troxerutin + hesperidin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call